8-K/A XBRL

FORM 8-K/A

Company: CATALYST PHARMACEUTICALS, INC.
Filed: April 10, 2023
Period of Report: January 24, 2023
Accession Number: 0001193125-23-096563

View Document ↗ View on SEC.gov ↗